EW vs JACK · P/E 47, rev $1.39B vs rev $1.47B
Edwards Lifesciences Corp (EW) versus Jacktel AS (JACK) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Jacktel AS (JACK) is a restaurants company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported JACK revenue for 2025-09-28 was $1.47B. Net income was -$80.7M. Revenue was down 6.7% from 2024-09-29 to 2025-09-28. JACK currently screens at market cap $215.9M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. JACK currently screens at market cap $215.9M.
Not investment advice. Open the EW and JACK stock pages for the full models.
Not investment advice.